中洪博元 z-bio 2021-07-06 3495

　　On the occasion of the centenary of the Communist Party of China, when the nation celebrates the party’s birthday, Zhonghong Boyuan’s monthly performance exceeded 10 million. To celebrate the state and family affairs, the third lobster banquet of Zhonghong Boyuan was grandly opened.

　　In June, Zhonghong Boyuan worked hard to carry forward the corporate values of “struggling people as the foundation” of Zhonghong people, and achieved a good result of the contract value of the transformation of scientific and technological achievements exceeding 10 million.

　　And use a song "My Motherland and Me" to sing the party to celebrate the party.

　　At this moment, we are gathered together, all because this is the party’s birthday, and it is also a time for all the people of Zhonghong to gather together. We laughed and laughed, and we toasted together.

      In a blink of an eye, 2021 has passed halfway. Looking back at the major new outbreak of COVID-19 at the beginning of 2020, and then to the preventive action of vaccinating all staff with the new crown virus this year, the new crown virus animal model created by Chinese scientists has rapidly developed drugs and vaccines for my country. , Made a significant contribution to the control of the epidemic. In response to the call of the Party Central Committee to strengthen the hard core of science and technology, Zhonghong Boyuan has prepared 206 animal models of diseases to provide research objects and platforms for life science experiments, CRO drug efficacy screening, drug metabolism, non-GLP safety evaluation, and the transformation of medical science and technology achievements. , To provide technical support for my country's drug research and development, medical and health industry development and response to major infectious diseases.

　　As life sciences and medical research enter new fields, the demand for animal models is increasing. Animal models are important experimental resources in the development of vaccines and drugs. In particular, research on major infectious diseases and complex human diseases requires stable and effective disease animal models as support. The company has established an experimental base of 4000 square meters, including an animal experiment center, a cell experiment center, a nucleic acid protein laboratory, a pathology laboratory, a molecular laboratory, a microbiology laboratory, a biological material laboratory, and other comprehensive experimental platforms. Complete the development of disease animal models covering the blood system, nervous system, cardiovascular system, digestive system, respiratory system, genitourinary system, endocrine system, skeletal muscle, skin, and eyes, ears, mouth, nose, and throat, and form a returnee doctor as an academic R&D echelon of leaders, professional technical R&D team with reasonable division of responsibilities. On this basis, a stable technical barrier has been formed at the rate of 50-100 animal models developed every year. Zhonghong Boyuan adheres to the integration of production, teaching and research, and has carried out technical cooperation with Nanchang University, Jiangxi University of Traditional Chinese Medicine, Jiangxi Agricultural University, and the Model Appraisal and Evaluation Committee of the Chinese Society of Laboratory Animals. Co-established with the Key Laboratory of Food Safety and Bioanalysis of the Ministry of Education of Fuzhou University Teaching platform to promote foreign exchanges in the animal model industry. It has recently become the innovation base for graduate education of Jiangxi University of Traditional Chinese Medicine.

　　Zhonghong Boyuan is committed to becoming the most professional biomedical service company in China with first-class technology and operation management, and actively exploring overseas markets. Customize the most effective experimental programs and animal models for global customers, efficiently promote the research and development process of new drugs and new therapies, and provide strong support and services for global drug research and development.